| Authors: |
Garland GD; MRC Toxicology Unit, Gleeson Building, Tennis Court Rd, Cambridge, U.K., Harvey RF; MRC Toxicology Unit, Gleeson Building, Tennis Court Rd, Cambridge, U.K., Mulroney TE; MRC Toxicology Unit, Gleeson Building, Tennis Court Rd, Cambridge, U.K., Monti M; MRC Toxicology Unit, Gleeson Building, Tennis Court Rd, Cambridge, U.K., Fuller S; Department of Medicine, University of Cambridge, Cambridge, U.K., Haigh R; Department of Respiratory Sciences, Maurice Shock Medical Sciences Building, University Road, Leicester, U.K., Gerber PP; Department of Medicine, University of Cambridge, Cambridge, U.K.; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), University of Cambridge, Cambridge, U.K., Barer MR; Department of Respiratory Sciences, Maurice Shock Medical Sciences Building, University Road, Leicester, U.K., Matheson NJ; Department of Medicine, University of Cambridge, Cambridge, U.K.; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), University of Cambridge, Cambridge, U.K.; NHS Blood and Transplant, Cambridge, U.K., Willis AE; MRC Toxicology Unit, Gleeson Building, Tennis Court Rd, Cambridge, U.K. |
